影响剂量学计算变异性的因素国际研究第3部分:时间积分活度计算吸收剂量的贡献
本研究基于美国核医学与分子影像学会(SNM)的177Lu剂量学挑战第5项任务,评估剂量学工作流最后一步剂量转换的变异性。2名医学物理师用不同软件、方法和所有可能的输入分割格式与时间点组合评估参考变异性,并对全球参与者的吸收剂量结果计算描述性统计和四分位离散系数。结果显示肝脏(含高摄取病灶)变异性高达36%,肝脏吸收剂量基线分析变异性29%,其他器官和病灶变异性在7%以内,剂量学方法或软件选择对总体剂量估计变异贡献较小。
要点
- 肝脏含高摄取病灶时吸收剂量变异性高达36%。
- 肝脏数据集合并纳入与排除病灶时吸收剂量变异性为29%。
- 其他器官和病灶变异性在7%以内,局部沉积法除外。
核心结论
- 剂量学方法或软件的选择对剂量估计的总体变异性贡献较小。
研究设计与样本
- 基于美国核医学与分子影像学会(SNM)177Lu剂量学挑战的第5项任务,该挑战共含5项任务评估剂量学工作流变异性。
- 参考变异性由2名医学物理师使用不同软件、方法和所有可能的输入分割格式与时间点组合进行评估。
- 对全球参与者提交的吸收剂量值计算一般描述性统计,并用四分位离散系数测量变异性。
主要发现
- 肝脏(包括高摄取病灶)的变异性高达36%。
- 肝脏吸收剂量基线分析中,将纳入病灶与排除病灶的数据集分组后变异性为29%,表明正常肝脏中病灶处理方式的差异是变异性的一大来源。
- 其他器官和病灶的变异性在7%以内,且与所用软件无关,局部沉积法除外。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Image-based dosimetry-guided radiopharmaceutical therapy has the potential to personalize treatment by limiting toxicity to organs at risk and maximizing the therapeutic effect. The 177Lu dosimetry challenge of the Society of Nuclear Medicine and Molecular Imaging consisted of 5 tasks assessing the variability in the dosimetry workflow. The fifth task investigated the variability associated with the last step, dose conversion, of the dosimetry workflow on which this study is based. Methods: Reference variability was assessed by 2 medical physicists using different software, methods, and all possible combinations of input segmentation formats and time points as provided in the challenge. General descriptive statistics for absorbed dose values from the global submissions from participants were calculated, and variability was measured using the quartile coefficient of dispersion. Results: For the liver, which included lesions with high uptake, variabilities of up to 36% were found. The baseline analysis showed a variability of 29% in absorbed dose results for the liver from datasets where lesions included and excluded were grouped, indicating that variation in how lesions in normal liver were treated was a significant source of variability. For other organs and lesions, variability was within 7%, independently of software used except for the local deposition method. Conclusion: The choice of dosimetry method or software had a small contribution to the overall variability of dose estimates.
引用
- Brosch-Lenz J, Kurkowska S, Frey E, et al. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity. J Nucl Med. 2024. PMID: 38960715. doi:10.2967/jnumed.123.267293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。